XYLYX
Xylyx Bio is a biotechnology company based in Brooklyn, New York, with integrated research and development laboratories and manufacturing facilities. The company specializes in the development, manufacturing, and commercialization of tissue-derived decellularized extracellular matrix (dECM) kits and assays for human disease modeling and drug testing. Leveraging its InMatrico® platform and TissueSpec® dECM product line, Xylyx Bio translates advances in extracellular matrix biology into standardized, scalable research tools. These products enable scientists to incorporate tissue-specific dECM into in-vitro models, enhancing physiological relevance and improving disease modeling fidelity. By more accurately recapitulating human tissue-specific extracellular microenvironments, Xylyx Bio is helping to bridge the gap between conventional laboratory models and human biology.
